National Research Corporation (NRC) Stock Price: $20.81+0.27 (+1.31%)
At close: Jun 26, 2026, 4:00 PM ET
The closing share price for National Research Corporation (NRC) stock was $20.81 for Friday, June 26, 2026, up 1.31% on the day.
Longer view (total return, dividends reinvested): past 12 months +34.0% · 3-year avg -20.1%/yr · 5-year avg -12.8%/yr
NRC Price Chart
NRC is featured in
NRC Key Metrics
See All MetricsLAST CLOSE PRICE
$20.81
52-WEEK RANGE
$11.01 - $22.79
BETA
0.40
% FROM 52W HIGH
-8.69%
MARKET CAP
$468.99M
DIVIDEND YIELD
3.46%
PE RATIO
trailing TTM
52.33
PE RATIO (FWD)
next-FY estimate
23.65
P/B RATIO
33.79
DEBT / EQUITY
5.65
REVENUE TTM
$138.64M
NET INCOME TTM
$9.03M
NET PROFIT MARGIN TTM
6.52%
TTM TOTAL RETURN
+34.03%
3Y TOTAL RETURN
-20.12%
5Y TOTAL RETURN
-12.81%
NRC Earnings Preview
Next Earnings Date
Jul 27, 2026
30 days away
EPS Estimate
-0.15
Revenue Est.
$34.90M
Last Quarter Results
EPS
$0.21
vs Estimate
$0.24
Revenue
$34.80M
vs Estimate
$40.00M
NRC Analyst Ratings
Consensus Rating
Based on 1 analyst
Average Price Target
$23.00
+10.5% upside
Low
$23.00
Current
$20.81
High
$23.00
NRC Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q3 2025 | $0.00 | $0.00 | $0.00 | 7 |
| Q2 2026 | $-0.15 | $-0.15 | $-0.15 | 1 |
| Q3 2026 | $0.15 | $0.15 | $0.15 | 1 |
| Q4 2026 | $0.19 | $0.19 | $0.19 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2025 | $0.81 | $0.81 | $0.81 | 1 |
| FY 2026 | $0.88 | $0.88 | $0.88 | 1 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q3 2025 | $34.61M | $34.61M | $34.61M | 6 |
| Q2 2026 | $34.90M | $34.90M | $34.90M | 1 |
| Q3 2026 | $35.60M | $35.60M | $35.60M | 1 |
| Q4 2026 | $36.60M | $36.60M | $36.60M | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2025 | $154.50M | $154.50M | $154.50M | 1 |
| FY 2026 | $118.30M | $118.30M | $118.30M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
HealthcareNRC Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1NRC | $468.99M | $20.81 | +1.31% | +34.03% | -12.81% | +6.34% | — |
| 2SI | $472.62M | $22.79 | +5.46% | N/A | N/A | N/A | vs NRC |
| 3ME | $15.31M | $0.61 | +0.00% | -67.07% | -68.93% | N/A | vs NRC |
| 4TDOC | $1.51B | $8.39 | +6.07% | +4.23% | -44.88% | -4.34% | vs NRC |
| 5XRAY | $2.21B | $11.01 | +2.13% | -28.65% | -28.20% | -14.57% | vs NRC |
| 6TMDX | $2.33B | $77.75 | +0.18% | -48.07% | +14.87% | N/A | vs NRC |
NRC Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green